| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 265 |
| 1 | INFLIXIMAB | 246 |
| 2 | RISANKIZUMAB-RZAA | 160 |
| 3 | UPADACITINIB | 84 |
| 4 | USTEKINUMAB | 81 |
| 5 | VEDOLIZUMAB | 65 |
| 6 | PREDNISONE | 61 |
| 7 | METHOTREXATE SODIUM | 47 |
| 8 | AZATHIOPRINE | 46 |
| 9 | METHOTREXATE | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROTRIPTYLINE HYDROCHLORIDE | 1 | 0.0104 |
| 1 | INFLIXIMAB-DYYB | 31 | 0.0090 |
| 2 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0058 |
| 3 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 4 | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | 1 | 0.0030 |
| 5 | LEVORPHANOL TARTRATE | 1 | 0.0027 |
| 6 | GOLIMUMAB | 21 | 0.0017 |
| 7 | ADALIMUMAB-AFZB | 4 | 0.0015 |
| 8 | BISACODYL 5MG | 1 | 0.0011 |
| 9 | INFLIXIMAB | 246 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 338 |
| 1 | Interleukin-23 Antagonist [EPC] | 243 |
| 2 | Corticosteroid [EPC] | 113 |
| 3 | Janus Kinase Inhibitor [EPC] | 87 |
| 4 | Interleukin-12 Antagonist [EPC] | 81 |
| 5 | Integrin Receptor Antagonist [EPC] | 76 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 7 | Purine Antimetabolite [EPC] | 47 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 43 |
| 9 | Proton Pump Inhibitor [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 14 | 0.0203 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 2 | Interleukin-23 Antagonist [EPC] | 243 | 0.0023 |
| 3 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 4 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 5 | Provitamin D2 Compound [EPC] | 27 | 0.0009 |
| 6 | Integrin Receptor Antagonist [EPC] | 76 | 0.0009 |
| 7 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 8 | Interleukin-12 Antagonist [EPC] | 81 | 0.0008 |
| 9 | Monoamine Oxidase Inhibitor [EPC] | 2 | 0.0006 |